Cleared Traditional

CATARHEX 3

K133562 · Oertli Instrumente AG · Ophthalmic
Aug 2014
Decision
265d
Days
Class 2
Risk

About This 510(k) Submission

K133562 is an FDA 510(k) clearance for the CATARHEX 3, a Unit, Phacofragmentation (Class II — Special Controls, product code HQC), submitted by Oertli Instrumente AG (Berneck, CH). The FDA issued a Cleared decision on August 12, 2014, 265 days after receiving the submission on November 20, 2013. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.4670.

Submission Details

510(k) Number K133562 FDA.gov
FDA Decision Cleared SESE
Date Received November 20, 2013
Decision Date August 12, 2014
Days to Decision 265 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code HQC — Unit, Phacofragmentation
Device Class Class II — Special Controls
CFR Regulation 21 CFR 886.4670

Similar Devices — HQC Unit, Phacofragmentation

All 313
System Sophi
K250501 · This AG · Nov 2025
MICOR 700 with Auto I/A
K243395 · Carl Zeiss Meditec Cataract Technology, Inc. · Aug 2025
MICOR 700 System (N/A); MICOR 700 drive (FG-50631); MICOR 700 extractor (FG-50621); MICOR 700 vitrector (FG-51185)
K242801 · Carl Zeiss Meditec Cataract Technology, Inc. · Jun 2025
Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)
K240169 · Bausch and Lomb, Incorporated · Jul 2024
Faros Surgical System
K233398 · Oertli Instrumente AG · Jun 2024
UNITY VCS (8065000296); UNITY CS (8065000297)
K233876 · Alcon Laboratories, Inc. · Jun 2024